← All Press Releases

Chief Judge Pallmeyer to Speak at Upcoming Paragraph IV Disputes Master Symposium

August 23, 2019

American Conference Institute is pleased to announce Chief Judge Pallmeyer as a featured speaker at its 7th Annual Paragraph IV Disputes Master Symposium on October 3 & 4, 2019 in Chicago.

As the industry prepares to address the fallout of global pharmaceutical patent losses of billions of dollars and the impact of evolving law, regulation and policy impacting the Hatch-Waxman landscape, the time for this conference has never been more relevant. This event is known to offer a one-of-a-kind opportunity to develop and perfect the offensive moves and defensive plays needed to meet the new challenges of Paragraph IV litigation.

Chief Judge Pallmeyer will examine decision-making practices employed by the judicial system and provide sage advice for both patent holders, and patent challengers.

Preeminent patent litigators representing brand name and generic drug makers will also provide key insights on:

  • Pending Hatch-Waxman reform measures which may impact your practice and change the balance of power between brand names and generics
  • The impact of new Section 101 and 112 challenges on ANDA litigation
  • Evolving Doctrine of Equivalents jurisprudence and how it is affecting Hatch-Waxman cases
  • Novel and strategic use of 12(b) and 12 (c) motions
  • The application of blocking patents post-Acorda
  • New developments impacting parallel proceedings
  • The economic impact of recent FDA activity affecting market access and exclusivities

The esteemed members of this year’s speaker faculty include:

United States District Court

Honorable Tonianne Bongiovanni
Magistrate Judge
District of New Jersey

Honorable Roy Payne
Magistrate Judge
Eastern District of Texas

Honorable Sidney I. Schenkier
Magistrate Judge
Northern District of Illinois 

United States Patent and Trademark Office, Patent Trial and Appeal Board

Honorable Jacqueline Wright Bonilla
Vice Chief Administrative Patent Judge

Honorable Michelle N. Ankenbrand
Lead Administrative Patent Judge

Honorable Rama G. Elluru
Administrative Patent Judge

Federal Trade Commission

James Weingarten
Attorney

Benchmark with industry leaders from:

  • AbbVie
  • Akorn Pharmaceuticals
  • Amneal Pharmaceuticals
  • Avanir Pharmaceuticals
  • Eagle Pharmaceuticals
  • Eli Lilly & Company
  • Fresenius Kabi, USA, LLC
  • Gilead Sciences
  • Genentech
  • Glenmark Pharmaceuticals
  • Ironwood Pharmaceuticals
  • Jounce Therapeutics
  • Mylan
  • Merus US
  • Takeda

Last year’s event sold out! ACI encourages all interested parties to reserve seats soon before the event fills to capacity again at www.AmericanConference.com/PIVDisputesChicago